Metagenomi, Inc. Common Stock
NASDAQ: MGX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jian Irish
- Employees
- 202
- Headquarters
- Emeryville, United States
- IPO year
- 2006
- Market cap
- $45.2M
- Website
- https://www.metagenomi.co
Loading MGX…
Loading profile data…Frequently asked questions about MGX
What does Metagenomi, Inc. Common Stock (MGX) do?
Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors,...
Where does MGX trade?
Metagenomi, Inc. Common Stock (MGX) trades on the NASDAQ Global Select.
What sector is MGX in?
Metagenomi, Inc. Common Stock (MGX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Metagenomi, Inc. Common Stock?
Jian Irish is the chief executive officer of Metagenomi, Inc. Common Stock (MGX).
Where is Metagenomi, Inc. Common Stock headquartered?
Metagenomi, Inc. Common Stock is headquartered in United States.
Does MGX pay a dividend?
Metagenomi, Inc. Common Stock (MGX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MGX go public?
Metagenomi, Inc. Common Stock (MGX) completed its initial public offering in 2006.